- Home
- SUPN vs BTSG Comparison
SUPN vs BTSG Comparison
Compare SUPN & BTSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- BTSG
- Stock Information
- Founded
- SUPN 2005
- BTSG 1974
- Country
- SUPN United States
- BTSG United States
- Employees
- SUPN N/A
- BTSG N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- BTSG
- Sector
- SUPN Health Care
- BTSG
- Exchange
- SUPN Nasdaq
- BTSG NYSE
- Market Cap
- SUPN 1.8B
- BTSG 4.1B
- IPO Year
- SUPN 2012
- BTSG 2024
- Fundamental
- Price
- SUPN $33.96
- BTSG $20.31
- Analyst Decision
- SUPN Hold
- BTSG Strong Buy
- Analyst Count
- SUPN 2
- BTSG 9
- Target Price
- SUPN $36.00
- BTSG $23.50
- AVG Volume (30 Days)
- SUPN 739.8K
- BTSG 2.6M
- Earning Date
- SUPN 08-05-2025
- BTSG 08-01-2025
- Dividend Yield
- SUPN N/A
- BTSG N/A
- EPS Growth
- SUPN N/A
- BTSG N/A
- EPS
- SUPN 1.11
- BTSG 0.29
- Revenue
- SUPN $667,997,000.00
- BTSG $11,858,835,000.00
- Revenue This Year
- SUPN N/A
- BTSG $11.55
- Revenue Next Year
- SUPN $12.02
- BTSG $12.14
- P/E Ratio
- SUPN $29.92
- BTSG $71.12
- Revenue Growth
- SUPN 11.82
- BTSG 30.55
- 52 Week Low
- SUPN $27.05
- BTSG $10.15
- 52 Week High
- SUPN $40.28
- BTSG $25.57
- Technical
- Relative Strength Index (RSI)
- SUPN 66.18
- BTSG 33.01
- Support Level
- SUPN $32.49
- BTSG $21.36
- Resistance Level
- SUPN $33.80
- BTSG $22.40
- Average True Range (ATR)
- SUPN 0.91
- BTSG 0.67
- MACD
- SUPN 0.23
- BTSG -0.29
- Stochastic Oscillator
- SUPN 99.37
- BTSG 5.96
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About BTSG BRIGHTSPRING HEALTH SERVICES INC
BrightSpring Health Services Inc is a home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services to complex patients. Its platform delivers clinical services and pharmacy solutions across Medicare, Medicaid, and commercially insured populations. Its segments include Pharmacy Solutions, Provider Services and others. It generates the majority of its revenue from the Pharmacy Solutions segment.